コーパス検索結果(共起頻度の集計）
検索語: make it
ヒット件数: 1000
| 一般的な頻出語を「文章内」のリストから除外しています |
| 2語前 |
1語前 |
|
1語後 |
2語後 |
|
文章内 |
| and |
35 |
have |
46 |
|
possible |
181 |
to |
433 |
|
possible |
194 |
| of |
34 |
which |
41 |
|
difficult |
167 |
for |
91 |
|
difficult |
187 |
| the |
24 |
that |
35 |
|
a |
151 |
promising |
24 |
|
high |
85 |
| this |
18 |
has |
28 |
|
an |
76 |
ideal |
21 |
|
however |
74 |
| in |
16 |
to |
26 |
|
more |
30 |
attractive |
19 |
|
data |
63 |
| these |
11 |
this |
23 |
|
the |
24 |
potential |
16 |
|
cells |
61 |
| to |
8 |
and |
21 |
|
challenging |
21 |
that |
15 |
|
target |
59 |
| technology |
7 |
thus |
17 |
|
suitable |
19 |
useful |
12 |
|
studies |
54 |
| cell |
7 |
now |
12 |
|
easier |
15 |
difficult |
11 |
|
cell |
50 |
| technologies |
6 |
also |
11 |
|
ideal |
12 |
and |
11 |
|
new |
49 |
| cells |
6 |
technology |
7 |
|
imperative |
10 |
suited |
10 |
|
based |
48 |
| with |
6 |
conditions |
7 |
|
particularly |
9 |
of |
10 |
|
low |
46 |
| by |
6 |
may |
7 |
|
impossible |
9 |
more |
8 |
|
study |
45 |
| is |
5 |
will |
7 |
|
important |
9 |
highly |
7 |
|
specific |
44 |
| based |
5 |
data |
7 |
|
feasible |
8 |
in |
7 |
|
use |
44 |
| specific |
5 |
approach |
6 |
|
unclear |
7 |
excellent |
7 |
|
applications |
43 |
| such |
5 |
system |
5 |
|
one |
7 |
suitable |
7 |
|
system |
43 |
| our |
5 |
interface |
4 |
|
hard |
7 |
the |
6 |
|
s |
42 |
| that |
5 |
can |
4 |
|
attractive |
6 |
good |
6 |
|
clinical |
42 |
| throughput |
4 |
materials |
4 |
|
promising |
6 |
potentially |
6 |
|
candidate |
40 |
| or |
4 |
1 |
4 |
|
unlikely |
6 |
important |
6 |
|
well |
39 |
| different |
4 |
decision |
4 |
|
highly |
6 |
appealing |
6 |
|
disease |
38 |
| experimental |
4 |
cells |
4 |
|
of |
6 |
challenging |
5 |
|
other |
38 |
| its |
4 |
profile |
3 |
|
accessible |
5 |
first |
5 |
|
identify |
37 |
| s |
4 |
specificity |
3 |
|
essential |
5 |
interesting |
5 |
|
tool |
37 |
| for |
4 |
material |
3 |
|
clear |
5 |
powerful |
5 |
|
protein |
36 |
| 3 |
4 |
domains |
3 |
|
easy |
5 |
effective |
4 |
|
highly |
36 |
| many |
4 |
species |
3 |
|
well |
4 |
valuable |
4 |
|
dna |
36 |
| genome |
3 |
receptors |
3 |
|
extremely |
4 |
impossible |
4 |
|
development |
36 |
| are |
3 |
time |
3 |
|
impractical |
4 |
major |
4 |
|
promising |
35 |
| spatial |
3 |
analysis |
3 |
|
very |
4 |
challenge |
4 |
|
model |
35 |
| a |
3 |
methods |
3 |
|
useful |
4 |
unique |
4 |
|
large |
35 |
| sequencing |
3 |
design |
3 |
|
to |
3 |
amenable |
3 |
|
ideal |
35 |
| conditions |
3 |
water |
3 |
|
almost |
3 |
than |
3 |
|
human |
34 |
| processing |
3 |
technique |
3 |
|
practical |
3 |
efficient |
3 |
|
both |
34 |
| rna |
3 |
expression |
3 |
|
critical |
3 |
largest |
3 |
|
potential |
34 |
| low |
3 |
effects |
3 |
|
amenable |
3 |
as |
3 |
|
time |
34 |
| techniques |
3 |
features |
3 |
|
increasingly |
3 |
viable |
3 |
|
many |
33 |
| methods |
3 |
cancers |
3 |
|
ideally |
3 |
how |
3 |
|
single |
31 |
| physiological |
3 |
disease |
3 |
|
likely |
3 |
likely |
3 |
|
attractive |
31 |
| drug |
3 |
should |
3 |
|
uniquely |
3 |
with |
3 |
|
using |
31 |
| cancer |
3 |
dna |
3 |
|
compatible |
3 |
or |
3 |
|
c |
31 |
| be |
3 |
cost |
3 |
|
much |
3 |
very |
3 |
|
genome |
30 |
| advances |
3 |
products |
3 |
|
susceptible |
3 |
competitive |
3 |
|
complex |
30 |
| which |
3 |
here |
3 |
|
less |
3 |
accessible |
3 |
|
function |
30 |
| binding |
3 |
platform |
3 |
|
available |
3 |
prime |
2 |
|
molecular |
30 |
| high |
3 |
disorder |
3 |
|
necessary |
2 |
clinical |
2 |
|
important |
29 |
| algorithm |
3 |
biology |
3 |
|
among |
2 |
adaptable |
2 |
|
suitable |
29 |
| tumor |
3 |
by |
3 |
|
easily |
2 |
a |
2 |
|
analysis |
29 |
| during |
3 |
pathways |
3 |
|
interesting |
2 |
common |
2 |
|
drug |
29 |
| activity |
3 |
techniques |
3 |
|
convenient |
2 |
fastest |
2 |
|
one |
29 |
| method |
3 |
stimuli |
2 |
|
nearly |
2 |
convenient |
2 |
|
genetic |
28 |
| biological |
3 |
sequencing |
2 |
|
past |
2 |
appropriate |
2 |
|
results |
28 |
| time |
3 |
technologies |
2 |
|
especially |
2 |
smallest |
2 |
|
cost |
28 |
| new |
3 |
samples |
2 |
|
complementary |
2 |
stable |
2 |
|
method |
28 |
| form |
3 |
levels |
2 |
|
potentially |
2 |
leading |
2 |
|
range |
28 |
| membrane |
3 |
structure |
2 |
|
so |
2 |
target |
2 |
|
challenging |
28 |
| studies |
2 |
women |
2 |
|
timely |
2 |
from |
2 |
|
unique |
28 |
| available |
2 |
vessels |
2 |
|
crucial |
2 |
only |
2 |
|
recent |
27 |
| plant |
2 |
thereby |
2 |
|
resistant |
2 |
robust |
2 |
|
patients |
26 |
| we |
2 |
performance |
2 |
|
simple |
2 |
most |
2 |
|
during |
26 |
| data |
2 |
frequency |
2 |
|
capable |
2 |
readily |
2 |
|
properties |
26 |
| same |
2 |
plants |
2 |
|
largely |
2 |
sensitive |
2 |
|
cancer |
26 |
| analysis |
2 |
nm |
2 |
|
significantly |
1 |
strong |
2 |
|
effects |
26 |
| blood |
2 |
temperature |
2 |
|
unavailable |
1 |
which |
2 |
|
different |
26 |
| protein |
2 |
methodology |
2 |
|
electro |
1 |
versatile |
2 |
|
structure |
26 |
| clinical |
2 |
detection |
2 |
|
inefficient |
1 |
mechanical |
1 |
|
methods |
25 |
| image |
2 |
characteristics |
2 |
|
vulnerable |
1 |
unusual |
1 |
|
surface |
25 |
| change |
2 |
decades |
2 |
|
electromagnetically |
1 |
high |
1 |
|
wide |
24 |
| range |
2 |
response |
2 |
|
determination |
1 |
hospitable |
1 |
|
useful |
24 |
| immune |
2 |
function |
2 |
|
theoretically |
1 |
bright |
1 |
|
research |
24 |
| engineering |
2 |
metastasis |
2 |
|
flexibly |
1 |
unreachable |
1 |
|
imaging |
24 |
| 5 |
2 |
availability |
2 |
|
analysis |
1 |
useless |
1 |
|
individual |
24 |
| methodology |
2 |
range |
2 |
|
often |
1 |
safe |
1 |
|
advances |
23 |
| sensitive |
2 |
environments |
2 |
|
difficultly |
1 |
modality |
1 |
|
available |
23 |
| laser |
2 |
used |
2 |
|
unique |
1 |
possible |
1 |
|
first |
23 |
| kinetics |
2 |
graphene |
2 |
|
still |
1 |
remarkably |
1 |
|
thus |
23 |
| features |
2 |
area |
2 |
|
problematic |
1 |
rational |
1 |
|
used |
23 |
| output |
2 |
studies |
2 |
|
adaptable |
1 |
available |
1 |
|
therapeutic |
23 |
| commonly |
2 |
them |
2 |
|
role |
1 |
superior |
1 |
|
nature |
23 |
| numerous |
2 |
cancer |
2 |
|
paramount |
1 |
biologically |
1 |
|
determine |
23 |
| system |
2 |
complexity |
2 |
|
straightforward |
1 |
integral |
1 |
|
activity |
23 |
| electronic |
2 |
structures |
2 |
|
worth |
1 |
enabling |
1 |
|
sequencing |
22 |
| gene |
2 |
genome |
2 |
|
suited |
1 |
reliable |
1 |
|
information |
22 |
| genomes |
2 |
targets |
2 |
|
optimal |
1 |
fragile |
1 |
|
into |
22 |
| sample |
2 |
brain |
2 |
|
nigh |
1 |
favorite |
1 |
|
sensitivity |
22 |
| onset |
2 |
progression |
2 |
|
smaller |
1 |
point |
1 |
|
any |
22 |
| 1 |
2 |
model |
2 |
|
operations |
1 |
broadly |
1 |
|
treatment |
22 |
| properties |
2 |
variants |
2 |
|
look |
1 |
advantageous |
1 |
|
rna |
22 |
| developed |
2 |
method |
2 |
|
efficient |
1 |
these |
1 |
|
understand |
22 |
| single |
2 |
assay |
2 |
|
truly |
1 |
whether |
1 |
|
changes |
22 |
| spectroscopy |
2 |
simplicity |
2 |
|
effect |
1 |
environmentally |
1 |
|
number |
22 |
| well |
2 |
directly |
2 |
|
understanding |
1 |
cornucopia |
1 |
|
binding |
22 |
| t |
2 |
genes |
2 |
|
competitive |
1 |
pursuing |
1 |
|
without |
22 |
| existing |
2 |
it |
2 |
|
primed |
1 |
absorptive |
1 |
|
interactions |
21 |
| early |
2 |
limitations |
2 |
|
too |
1 |
second |
1 |
|
design |
21 |
| brain |
2 |
states |
2 |
|
energy |
1 |
perfect |
1 |
|
gene |
21 |
| between |
2 |
often |
2 |
|
agonistic |
1 |
on |
1 |
|
sequence |
21 |
| molecular |
2 |
platforms |
2 |
|
sensitive |
1 |
topic |
1 |
|
scale |
21 |
| active |
2 |
patient |
2 |
|
associated |
1 |
two |
1 |
|
conditions |
21 |
| antibodies |
2 |
scenarios |
2 |
|
conductive |
1 |
scalable |
1 |
|
approach |
21 |
| order |
2 |
understood |
2 |
|
applicable |
1 |
prone |
1 |
|
predict |
21 |
| health |
2 |
mice |
2 |
|
widely |
1 |
easy |
1 |
|
multiple |
20 |
| response |
2 |
oscillations |
2 |
|
volumetrically |
1 |
intensive |
1 |
|
technology |
20 |
| resistance |
2 |
factors |
2 |
|
best |
1 |
porting |
1 |
|
species |
20 |
| reaction |
2 |
preparation |
2 |
|
distinct |
1 |
rigid |
1 |
|
proteins |
20 |
| disease |
2 |
survival |
2 |
|
quantitative |
1 |
cocaine |
1 |
|
about |
19 |
| electric |
2 |
systems |
2 |
|
reproducible |
1 |
applicable |
1 |
|
control |
19 |
| poorly |
2 |
would |
2 |
|
prudent |
1 |
evolutionary |
1 |
|
rapid |
19 |
| architecture |
2 |
proteins |
2 |
|
chromophore |
1 |
nanomolar |
1 |
|
only |
19 |
| flow |
2 |
at |
2 |
|
run |
1 |
larger |
1 |
|
known |
19 |
| disequilibrium |
2 |
could |
2 |
|
way |
1 |
proinflammatory |
1 |
|
platform |
19 |
| developments |
2 |
probes |
2 |
|
active |
1 |
imperative |
1 |
|
major |
19 |
| thalamocortical |
2 |
gwass |
1 |
|
unfit |
1 |
generalizable |
1 |
|
expression |
19 |
| gas |
2 |
compute |
1 |
|
simpler |
1 |
description |
1 |
|
ability |
19 |
| one |
2 |
freedom |
1 |
|
dangerous |
1 |
relatively |
1 |
|
several |
19 |
| reproducibility |
2 |
pistil |
1 |
|
stateless |
1 |
fluoresce |
1 |
|
dynamics |
19 |
| was |
2 |
deleted |
1 |
|
seem |
1 |
potent |
1 |
|
factors |
19 |
| food |
2 |
ipv |
1 |
|
usage |
1 |
mn |
1 |
|
across |
19 |
| has |
2 |
communities |
1 |
|
remains |
1 |
interest |
1 |
|
brain |
19 |
| cost |
2 |
etc |
1 |
|
worthwhile |
1 |
key |
1 |
|
biological |
19 |
| when |
2 |
ovaries |
1 |
|
hitherto |
1 |
preferred |
1 |
|
show |
19 |
| thermal |
2 |
seafood |
1 |
|
reasonable |
1 |
arduous |
1 |
|
effect |
18 |
| ms |
2 |
over |
1 |
|
appear |
1 |
worthwhile |
1 |
|
technologies |
18 |
| years |
1 |
homogeneity |
1 |
|
ampar |
1 |
into |
1 |
|
including |
18 |
| fear |
1 |
potentially |
1 |
|
either |
1 |
trifunctional |
1 |
|
because |
18 |
| pk |
1 |
masses |
1 |
|
both |
1 |
particular |
1 |
|
over |
18 |
| graphical |
1 |
who |
1 |
|
kinetic |
1 |
able |
1 |
|
field |
18 |
| advantages |
1 |
ability |
1 |
|
appropriate |
1 |
even |
1 |
|
e |
18 |
| vaccines |
1 |
flypi |
1 |
|
safer |
1 |
candidate |
1 |
|
often |
18 |
| materials |
1 |
cone |
1 |
|
readily |
1 |
our |
1 |
|
experimental |
18 |
| crossing |
1 |
well |
1 |
|
is |
1 |
well |
1 |
|
resolution |
18 |
| field |
1 |
records |
1 |
|
addictive |
1 |
at |
1 |
|
current |
17 |
| prototyping |
1 |
piperaquine |
1 |
|
mandatory |
1 |
central |
1 |
|
risk |
17 |
| line |
1 |
operation |
1 |
|
direct |
1 |
cacheable |
1 |
|
i |
17 |
| solar |
1 |
milliseconds |
1 |
|
switch |
1 |
unlikely |
1 |
|
assess |
17 |
| transcription |
1 |
overexpressed |
1 |
|
economic |
1 |
bona |
1 |
|
all |
17 |
| space |
1 |
ultrasonography |
1 |
|
breeding |
1 |
grow |
1 |
|
level |
17 |
| background |
1 |
constraints |
1 |
|
complicated |
1 |
better |
1 |
|
long |
17 |
| sm |
1 |
targeting |
1 |
|
unusual |
1 |
generic |
1 |
|
detection |
17 |
| research |
1 |
operations |
1 |
|
activation |
1 |
unclear |
1 |
|
two |
17 |
| sds |
1 |
coli |
1 |
|
may |
1 |
if |
1 |
|
techniques |
17 |
| him |
1 |
property |
1 |
|
conceptually |
1 |
devastating |
1 |
|
directly |
17 |
| rate |
1 |
perform |
1 |
|
metastatic |
1 |
compelling |
1 |
|
type |
17 |
| marine |
1 |
shortcoming |
1 |
|
functional |
1 |
increasing |
1 |
|
models |
17 |
| enzyme |
1 |
membrane |
1 |
|
isotope |
1 |
hotspot |
1 |
|
role |
17 |
| saliva |
1 |
gene |
1 |
|
encodes |
1 |
linear |
1 |
|
features |
17 |
| cognitive |
1 |
infiltration |
1 |
|
different |
1 |
like |
1 |
|
even |
17 |
| extensions |
1 |
relationships |
1 |
|
beneficial |
1 |
also |
1 |
|
complexity |
16 |
| grass |
1 |
settings |
1 |
|
binding |
1 |
metallic |
1 |
|
receptor |
16 |
| pip2 |
1 |
contrast |
1 |
|
portable |
1 |
characterization |
1 |
|
impossible |
16 |
| psychological |
1 |
elsewhere |
1 |
|
unnecessary |
1 |
cheaper |
1 |
|
limited |
16 |
| e |
1 |
cities |
1 |
|
key |
1 |
tool |
1 |
|
associated |
16 |
| broadcasting |
1 |
devices |
1 |
|
|
|
faster |
1 |
|
among |
16 |
| affect |
1 |
region |
1 |
|
|
|
largely |
1 |
|
easier |
16 |
| routes |
1 |
chemosensor |
1 |
|
|
|
hazardous |
1 |
|
provide |
16 |
| separation |
1 |
expansion |
1 |
|
|
|
paradigm |
1 |
|
ion |
16 |
| way |
1 |
exists |
1 |
|
|
|
engineering |
1 |
|
under |
16 |
| er |
1 |
ions |
1 |
|
|
|
indispensable |
1 |
|
structural |
16 |
| given |
1 |
geometry |
1 |
|
|
|
method |
1 |
|
very |
16 |
| fire |
1 |
reproducibility |
1 |
|
|
|
great |
1 |
|
effective |
16 |
| aggressive |
1 |
adhesion |
1 |
|
|
|
detection |
1 |
|
detect |
16 |
| peroxidase |
1 |
formats |
1 |
|
|
|
widely |
1 |
|
structures |
16 |
| etd |
1 |
particles |
1 |
|
|
|
between |
1 |
|
response |
16 |
| spectral |
1 |
rates |
1 |
|
|
|
catastrophic |
1 |
|
functional |
16 |
| progression |
1 |
chamber |
1 |
|
|
|
prototype |
1 |
|
early |
16 |
| starch |
1 |
magnitudes |
1 |
|
|
|
alternative |
1 |
|
novel |
15 |
| pathways |
1 |
spectroscopy |
1 |
|
|
|
shortest |
1 |
|
vivo |
15 |
| calibrating |
1 |
usually |
1 |
|
|
|
technique |
1 |
|
state |
15 |
| concentrations |
1 |
adulteration |
1 |
|
|
|
unsuitable |
1 |
|
particularly |
15 |
| dissimilar |
1 |
source |
1 |
|
|
|
site |
1 |
|
less |
15 |
| material |
1 |
pipelines |
1 |
|
|
|
resistant |
1 |
|
change |
15 |
| neuroanatomical |
1 |
productivity |
1 |
|
|
|
expensive |
1 |
|
materials |
15 |
| good |
1 |
tools |
1 |
|
|
|
standard |
1 |
|
tissue |
15 |
| temperatures |
1 |
novo |
1 |
|
|
|
when |
1 |
|
approaches |
15 |
| room |
1 |
tool |
1 |
|
|
|
functional |
1 |
|
host |
15 |
| rotavirus |
1 |
signals |
1 |
|
|
|
technical |
1 |
|
now |
15 |
| error |
1 |
ost |
1 |
|
|
|
within |
1 |
|
further |
15 |
| continuous |
1 |
period |
1 |
|
|
|
both |
1 |
|
mass |
15 |
| targeted |
1 |
step |
1 |
|
|
|
feasible |
1 |
|
although |
15 |
| t2dir |
1 |
readout |
1 |
|
|
|
current |
1 |
|
infection |
15 |
| population |
1 |
scientists |
1 |
|
|
|
favourable |
1 |
|
growth |
15 |
| diversity |
1 |
ten |
1 |
|
|
|
twice |
1 |
|
common |
15 |
| cytometry |
1 |
viability |
1 |
|
|
|
user |
1 |
|
spatial |
15 |
| compounds |
1 |
annulus |
1 |
|
|
|
composition |
1 |
|
processes |
15 |
| standardized |
1 |
coeruleus |
1 |
|
|
|
condition |
1 |
|
ms |
15 |
| also |
1 |
stages |
1 |
|
|
|
identifiable |
1 |
|
demonstrate |
15 |
| primary |
1 |
metabolism |
1 |
|
|
|
desirable |
1 |
|
resistance |
15 |
| performance |
1 |
direction |
1 |
|
|
|
permissive |
1 |
|
neurons |
15 |
| flexible |
1 |
basophils |
1 |
|
|
|
by |
1 |
|
molecules |
15 |
| de |
1 |
content |
1 |
|
|
|
impractical |
1 |
|
active |
15 |
| compact |
1 |
partners |
1 |
|
|
|
through |
1 |
|
systems |
15 |
| methacrylate |
1 |
quantified |
1 |
|
|
|
relevant |
1 |
|
suited |
14 |
| l |
1 |
alterations |
1 |
|
|
|
|
|
|
plant |
14 |
| cerevisiae |
1 |
theory |
1 |
|
|
|
|
|
|
excellent |
14 |
| year |
1 |
ionization |
1 |
|
|
|
|
|
|
relative |
14 |
| rinsing |
1 |
problems |
1 |
|
|
|
|
|
|
membrane |
14 |
| final |
1 |
biosensor |
1 |
|
|
|
|
|
|
up |
14 |
| younger |
1 |
morphogenesis |
1 |
|
|
|
|
|
|
samples |
14 |
| substrates |
1 |
pd |
1 |
|
|
|
|
|
|
g |
14 |
| sjs |
1 |
chemicals |
1 |
|
|
|
|
|
|
few |
14 |
| plasmonic |
1 |
considerably |
1 |
|
|
|
|
|
|
virus |
14 |
| reduced |
1 |
tryptophan |
1 |
|
|
|
|
|
|
tumor |
14 |
| beta |
1 |
2 |
1 |
|
|
|
|
|
|
combined |
14 |
| breakthroughs |
1 |
eg |
1 |
|
|
|
|
|
|
performance |
14 |
| stentor |
1 |
deformation |
1 |
|
|
|
|
|
|
addition |
14 |
| orchestrated |
1 |
discovery |
1 |
|
|
|
|
|
|
disorder |
13 |
| maglev |
1 |
properties |
1 |
|
|
|
|
|
|
no |
13 |
| water |
1 |
pair |
1 |
|
|
|
|
|
|
responses |
13 |
| either |
1 |
humans |
1 |
|
|
|
|
|
|
population |
13 |
| reported |
1 |
centrosomes |
1 |
|
|
|
|
|
|
potentially |
13 |
| micromolar |
1 |
metabolomics |
1 |
|
|
|
|
|
|
presence |
13 |
| combination |
1 |
oligomers |
1 |
|
|
|
|
|
|
present |
13 |
| sedimentary |
1 |
conformation |
1 |
|
|
|
|
|
|
states |
13 |
| nutrient |
1 |
waves |
1 |
|
|
|
|
|
|
levels |
13 |
| coupling |
1 |
axis |
1 |
|
|
|
|
|
|
strong |
13 |
| milestoning |
1 |
firing |
1 |
|
|
|
|
|
|
alternative |
13 |
| pressure |
1 |
perception |
1 |
|
|
|
|
|
|
throughput |
13 |
| strategy |
1 |
inhibition |
1 |
|
|
|
|
|
|
production |
13 |
| photoelectrode |
1 |
datasets |
1 |
|
|
|
|
|
|
cellular |
13 |
| temperature |
1 |
cord |
1 |
|
|
|
|
|
|
health |
13 |
| methodological |
1 |
software |
1 |
|
|
|
|
|
|
sample |
13 |
| zika |
1 |
reagent |
1 |
|
|
|
|
|
|
point |
13 |
| test |
1 |
cucumber |
1 |
|
|
|
|
|
|
area |
13 |
| founder |
1 |
services |
1 |
|
|
|
|
|
|
chemical |
13 |
| light |
1 |
matrix |
1 |
|
|
|
|
|
|
mechanisms |
13 |
| models |
1 |
sensitivity |
1 |
|
|
|
|
|
|
dynamic |
13 |
| complexity |
1 |
proviruses |
1 |
|
|
|
|
|
|
energy |
13 |
| any |
1 |
2vfeo6 |
1 |
|
|
|
|
|
|
combination |
13 |
| vary |
1 |
example |
1 |
|
|
|
|
|
|
if |
13 |
| dry |
1 |
anode |
1 |
|
|
|
|
|
|
selective |
13 |
| repertoires |
1 |
catalyst |
1 |
|
|
|
|
|
|
electron |
13 |
| interactions |
1 |
inheritance |
1 |
|
|
|
|
|
|
compared |
13 |
| 04mm |
1 |
acetylcholine |
1 |
|
|
|
|
|
|
immune |
12 |
| countervailing |
1 |
role |
1 |
|
|
|
|
|
|
non |
12 |
| survival |
1 |
malaria |
1 |
|
|
|
|
|
|
each |
12 |
| tunability |
1 |
bandgap |
1 |
|
|
|
|
|
|
signaling |
12 |
| reflected |
1 |
fold |
1 |
|
|
|
|
|
|
functions |
12 |
| mind |
1 |
transmission |
1 |
|
|
|
|
|
|
screening |
12 |
| tregs |
1 |
ecosystem |
1 |
|
|
|
|
|
|
global |
12 |
| operating |
1 |
meal |
1 |
|
|
|
|
|
|
material |
12 |
| neuronal |
1 |
selectivity |
1 |
|
|
|
|
|
|
develop |
12 |
| but |
1 |
intervention |
1 |
|
|
|
|
|
|
sequences |
12 |
| pattern |
1 |
enzymes |
1 |
|
|
|
|
|
|
efficient |
12 |
| spinal |
1 |
record |
1 |
|
|
|
|
|
|
some |
12 |
| art |
1 |
trials |
1 |
|
|
|
|
|
|
previously |
12 |
| chemodosimetric |
1 |
varies |
1 |
|
|
|
|
|
|
technique |
12 |
| infecting |
1 |
these |
1 |
|
|
|
|
|
|
critical |
12 |
| produces |
1 |
signaling |
1 |
|
|
|
|
|
|
reaction |
12 |
| 2 |
1 |
plasma |
1 |
|
|
|
|
|
|
types |
12 |
| problems |
1 |
evolution |
1 |
|
|
|
|
|
|
various |
12 |
| size |
1 |
mutualisms |
1 |
|
|
|
|
|
|
carbon |
12 |
| crystals |
1 |
metals |
1 |
|
|
|
|
|
|
pathway |
12 |
| zn |
1 |
measure |
1 |
|
|
|
|
|
|
drugs |
12 |
| bifunctional |
1 |
synthetase |
1 |
|
|
|
|
|
|
small |
12 |
| monogenic |
1 |
channels |
1 |
|
|
|
|
|
|
pathways |
12 |
| late |
1 |
agents |
1 |
|
|
|
|
|
|
challenge |
12 |
| replicons |
1 |
desktop |
1 |
|
|
|
|
|
|
visual |
12 |
| plane |
1 |
ssem |
1 |
|
|
|
|
|
|
coupled |
12 |
| key |
1 |
infection |
1 |
|
|
|
|
|
|
likely |
12 |
| severe |
1 |
eukaryotes |
1 |
|
|
|
|
|
|
existing |
12 |
| annotated |
1 |
accuracy |
1 |
|
|
|
|
|
|
especially |
12 |
| approach |
1 |
chemistry |
1 |
|
|
|
|
|
|
neuronal |
12 |
| anisotropic |
1 |
instability |
1 |
|
|
|
|
|
|
site |
12 |
| million |
1 |
not |
1 |
|
|
|
|
|
|
10 |
12 |
| tool |
1 |
are |
1 |
|
|
|
|
|
|
biology |
12 |
| marks |
1 |
pocket |
1 |
|
|
|
|
|
|
size |
11 |
| tension |
1 |
effect |
1 |
|
|
|
|
|
|
suggest |
11 |
| seq |
1 |
manually |
1 |
|
|
|
|
|
|
measure |
11 |
| across |
1 |
omega6 |
1 |
|
|
|
|
|
|
easy |
11 |
| mobility |
1 |
accumulation |
1 |
|
|
|
|
|
|
quality |
11 |
| deeper |
1 |
pairing |
1 |
|
|
|
|
|
|
related |
11 |
| 77 |
1 |
networks |
1 |
|
|
|
|
|
|
evolution |
11 |
| microbial |
1 |
amo |
1 |
|
|
|
|
|
|
vitro |
11 |
| c4 |
1 |
counterparts |
1 |
|
|
|
|
|
|
robust |
11 |
| unpredictability |
1 |
but |
1 |
|
|
|
|
|
|
genes |
11 |
| hydrophobicity |
1 |
wells |
1 |
|
|
|
|
|
|
specificity |
11 |
| oil |
1 |
electrode |
1 |
|
|
|
|
|
|
stability |
11 |
| manual |
1 |
loops |
1 |
|
|
|
|
|
|
physiological |
11 |
| e2 |
1 |
wgs |
1 |
|
|
|
|
|
|
targeted |
11 |
| geologic |
1 |
fates |
1 |
|
|
|
|
|
|
trials |
11 |
| differentiation |
1 |
metagenomics |
1 |
|
|
|
|
|
|
found |
11 |
| nociceptive |
1 |
observations |
1 |
|
|
|
|
|
|
phase |
11 |
| profiles |
1 |
modifications |
1 |
|
|
|
|
|
|
differences |
11 |
| animal |
1 |
ecg |
1 |
|
|
|
|
|
|
discovery |
11 |
| dividing |
1 |
growth |
1 |
|
|
|
|
|
|
synthesis |
11 |
| understanding |
1 |
bond |
1 |
|
|
|
|
|
|
events |
11 |
| protection |
1 |
individuals |
1 |
|
|
|
|
|
|
flow |
11 |
| photoinitiators |
1 |
amount |
1 |
|
|
|
|
|
|
beta |
11 |
| gross |
1 |
case |
1 |
|
|
|
|
|
|
receptors |
11 |
| predictions |
1 |
infancy |
1 |
|
|
|
|
|
|
furthermore |
11 |
| application |
1 |
algorithm |
1 |
|
|
|
|
|
|
acid |
11 |
| instrumentation |
1 |
microscopy |
1 |
|
|
|
|
|
|
water |
11 |
| trna |
1 |
resolution |
1 |
|
|
|
|
|
|
generation |
11 |
| finding |
1 |
unsynchronized |
1 |
|
|
|
|
|
|
decision |
11 |
| antifungal |
1 |
androgens |
1 |
|
|
|
|
|
|
through |
11 |
| levels |
1 |
0 |
1 |
|
|
|
|
|
|
memory |
11 |
| microct |
1 |
catalysts |
1 |
|
|
|
|
|
|
observed |
11 |
| microscopy |
1 |
sds |
1 |
|
|
|
|
|
|
survival |
11 |
| heart |
1 |
strains |
1 |
|
|
|
|
|
|
work |
11 |
| sperm |
1 |
surveillance |
1 |
|
|
|
|
|
|
imperative |
11 |
| psychiatric |
1 |
ctcs |
1 |
|
|
|
|
|
|
interest |
11 |
| enhanced |
1 |
cecs |
1 |
|
|
|
|
|
|
patient |
10 |
| proteome |
1 |
neurons |
1 |
|
|
|
|
|
|
evaluate |
10 |
| 5am |
1 |
behavior |
1 |
|
|
|
|
|
|
reduce |
10 |
| src |
1 |
available |
1 |
|
|
|
|
|
|
mechanical |
10 |
| chosen |
1 |
dsas |
1 |
|
|
|
|
|
|
food |
10 |
| diazoether |
1 |
inexpensive |
1 |
|
|
|
|
|
|
key |
10 |
| risk |
1 |
epistasis |
1 |
|
|
|
|
|
|
increasing |
10 |
| mechanisms |
1 |
overwhelming |
1 |
|
|
|
|
|
|
studying |
10 |
| reporting |
1 |
events |
1 |
|
|
|
|
|
|
yet |
10 |
| input |
1 |
reporting |
1 |
|
|
|
|
|
|
good |
10 |
| did |
1 |
environment |
1 |
|
|
|
|
|
|
enzyme |
10 |
| preparation |
1 |
circuitry |
1 |
|
|
|
|
|
|
therapy |
10 |
| stark |
1 |
20 |
1 |
|
|
|
|
|
|
diseases |
10 |
| performed |
1 |
gei |
1 |
|
|
|
|
|
|
understanding |
10 |
| channel |
1 |
sensor |
1 |
|
|
|
|
|
|
practical |
10 |
| framework |
1 |
diversity |
1 |
|
|
|
|
|
|
short |
10 |
| bacterial |
1 |
synthesis |
1 |
|
|
|
|
|
|
regions |
10 |
| h |
1 |
c |
1 |
|
|
|
|
|
|
developed |
10 |
| cytoskeletal |
1 |
programmes |
1 |
|
|
|
|
|
|
environments |
10 |
| purification |
1 |
ozone |
1 |
|
|
|
|
|
|
channel |
10 |
| isolation |
1 |
substrates |
1 |
|
|
|
|
|
|
process |
10 |
| backbone |
1 |
marker |
1 |
|
|
|
|
|
|
induced |
10 |
| seasonal |
1 |
information |
1 |
|
|
|
|
|
|
t |
10 |
| nps |
1 |
lattice |
1 |
|
|
|
|
|
|
hiv |
10 |
| private |
1 |
hams |
1 |
|
|
|
|
|
|
essential |
10 |
| imaging |
1 |
11 |
1 |
|
|
|
|
|
|
particular |
10 |
| working |
1 |
haunt |
1 |
|
|
|
|
|
|
sensitive |
10 |
| toxicity |
1 |
regulators |
1 |
|
|
|
|
|
|
clear |
10 |
| wide |
1 |
concentrations |
1 |
|
|
|
|
|
|
moreover |
10 |
| observed |
1 |
europe |
1 |
|
|
|
|
|
|
like |
10 |
| surface |
1 |
g |
1 |
|
|
|
|
|
|
expressed |
10 |
| biosensing |
1 |
thc |
1 |
|
|
|
|
|
|
variants |
10 |
| mini |
1 |
activity |
1 |
|
|
|
|
|
|
microscopy |
10 |
| extinct |
1 |
assays |
1 |
|
|
|
|
|
|
density |
10 |
| homogenous |
1 |
outcome |
1 |
|
|
|
|
|
|
environment |
10 |
| redox |
1 |
parameter |
1 |
|
|
|
|
|
|
antibodies |
10 |
| hcm |
1 |
exponentially |
1 |
|
|
|
|
|
|
3d |
10 |
| codons |
1 |
state |
1 |
|
|
|
|
|
|
x |
10 |
| mortem |
1 |
modes |
1 |
|
|
|
|
|
|
mediated |
9 |
| disulfide |
1 |
index |
1 |
|
|
|
|
|
|
significant |
9 |
| organoid |
1 |
advancements |
1 |
|
|
|
|
|
|
profile |
9 |
| cocaine |
1 |
efficient |
1 |
|
|
|
|
|
|
significantly |
9 |
| tissue |
1 |
forces |
1 |
|
|
|
|
|
|
value |
9 |
| cellulosic |
1 |
integration |
1 |
|
|
|
|
|
|
independent |
9 |
| calm |
1 |
analyte |
1 |
|
|
|
|
|
|
environmental |
9 |
| regulation |
1 |
crosses |
1 |
|
|
|
|
|
|
increase |
9 |
| brightness |
1 |
rics |
1 |
|
|
|
|
|
|
evolutionary |
9 |
| t807 |
1 |
grain |
1 |
|
|
|
|
|
|
conventional |
9 |
| proposed |
1 |
implementations |
1 |
|
|
|
|
|
|
feasible |
9 |
| electrodes |
1 |
episode |
1 |
|
|
|
|
|
|
natural |
9 |
| power |
1 |
diseases |
1 |
|
|
|
|
|
|
evidence |
9 |
| inherent |
1 |
span |
1 |
|
|
|
|
|
|
intervention |
9 |
| pathway |
1 |
braunii |
1 |
|
|
|
|
|
|
three |
9 |
| na |
1 |
paper |
1 |
|
|
|
|
|
|
fully |
9 |
| methodologies |
1 |
sb |
1 |
|
|
|
|
|
|
diagnostic |
9 |
| results |
1 |
co2 |
1 |
|
|
|
|
|
|
rate |
9 |
| role |
1 |
coverage |
1 |
|
|
|
|
|
|
therefore |
9 |
| ocular |
1 |
simpler |
1 |
|
|
|
|
|
|
gas |
9 |
| dreadds |
1 |
gpa |
1 |
|
|
|
|
|
|
relatively |
9 |
| cl |
1 |
similarity |
1 |
|
|
|
|
|
|
precise |
9 |
| tetraploid |
1 |
protocol |
1 |
|
|
|
|
|
|
strategies |
9 |
| possible |
1 |
therapies |
1 |
|
|
|
|
|
|
native |
9 |
| fabricated |
1 |
pathogenesis |
1 |
|
|
|
|
|
|
liver |
9 |
| glp |
1 |
algorithms |
1 |
|
|
|
|
|
|
metabolic |
9 |
| moderate |
1 |
hairpins |
1 |
|
|
|
|
|
|
assay |
9 |
| neuroimaging |
1 |
pathogens |
1 |
|
|
|
|
|
|
underlying |
9 |
| wall |
1 |
is |
1 |
|
|
|
|
|
|
voltage |
9 |
| degrees |
1 |
fluids |
1 |
|
|
|
|
|
|
application |
9 |
| platforms |
1 |
mutation |
1 |
|
|
|
|
|
|
achieve |
9 |
| over |
1 |
versa |
1 |
|
|
|
|
|
|
light |
9 |
| mood |
1 |
field |
1 |
|
|
|
|
|
|
simple |
9 |
| crystallinity |
1 |
resistance |
1 |
|
|
|
|
|
|
characteristics |
9 |
| paracrystalline |
1 |
infrastructure |
1 |
|
|
|
|
|
|
accessible |
9 |
| raw |
1 |
clearance |
1 |
|
|
|
|
|
|
metabolism |
9 |
| machinery |
1 |
i |
1 |
|
|
|
|
|
|
settings |
9 |
| rising |
1 |
twitter |
1 |
|
|
|
|
|
|
h |
9 |
| btk |
1 |
group |
1 |
|
|
|
|
|
|
estimate |
9 |
| spectrometry |
1 |
framework |
1 |
|
|
|
|
|
|
transient |
9 |
| phenotype |
1 |
shrna |
1 |
|
|
|
|
|
|
impact |
9 |
| circulating |
1 |
market |
1 |
|
|
|
|
|
|
composition |
9 |
| 10 |
1 |
tissue |
1 |
|
|
|
|
|
|
analytical |
9 |
| oral |
1 |
vibrations |
1 |
|
|
|
|
|
|
magnitude |
9 |
| circumstances |
1 |
worldwide |
1 |
|
|
|
|
|
|
source |
9 |
| analytical |
1 |
cell |
1 |
|
|
|
|
|
|
primary |
9 |
| growing |
1 |
short |
1 |
|
|
|
|
|
|
unclear |
9 |
| undefined |
1 |
transformation |
1 |
|
|
|
|
|
|
experiments |
9 |
| labile |
1 |
wall |
1 |
|
|
|
|
|
|
products |
9 |
| circulation |
1 |
literature |
1 |
|
|
|
|
|
|
form |
9 |
| genetics |
1 |
use |
1 |
|
|
|
|
|
|
optical |
9 |
| xcuxas |
1 |
fields |
1 |
|
|
|
|
|
|
need |
9 |
| produced |
1 |
signal |
1 |
|
|
|
|
|
|
molecule |
9 |
| evolutionary |
1 |
less |
1 |
|
|
|
|
|
|
maintain |
9 |
| refractive |
1 |
what |
1 |
|
|
|
|
|
|
required |
9 |
| electrode |
1 |
syntax |
1 |
|
|
|
|
|
|
making |
9 |
| memory |
1 |
control |
1 |
|
|
|
|
|
|
regulation |
9 |
| eukaryotic |
1 |
mechanism |
1 |
|
|
|
|
|
|
allows |
9 |
| characteristics |
1 |
impermeant |
1 |
|
|
|
|
|
|
address |
8 |
| external |
1 |
burial |
1 |
|
|
|
|
|
|
traits |
8 |
| subjects |
1 |
flexibility |
1 |
|
|
|
|
|
|
frequency |
8 |
| software |
1 |
carcinomas |
1 |
|
|
|
|
|
|
stress |
8 |
| 2006 |
1 |
inflammation |
1 |
|
|
|
|
|
|
metal |
8 |
| b |
1 |
h |
1 |
|
|
|
|
|
|
characterized |
8 |
| 065 |
1 |
decrease |
1 |
|
|
|
|
|
|
degrees |
8 |
| microfluidic |
1 |
selective |
1 |
|
|
|
|
|
|
physical |
8 |
| analyte |
1 |
points |
1 |
|
|
|
|
|
|
mutations |
8 |
| computational |
1 |
reconstructions |
1 |
|
|
|
|
|
|
progression |
8 |
| structurally |
1 |
types |
1 |
|
|
|
|
|
|
user |
8 |
| markers |
1 |
involved |
1 |
|
|
|
|
|
|
friendly |
8 |
| quaternary |
1 |
interpreted |
1 |
|
|
|
|
|
|
ligand |
8 |
| price |
1 |
glass |
1 |
|
|
|
|
|
|
either |
8 |
| toxic |
1 |
analogs |
1 |
|
|
|
|
|
|
future |
8 |
| clozapine |
1 |
reaction |
1 |
|
|
|
|
|
|
tools |
8 |
| 450k |
1 |
autophagy |
1 |
|
|
|
|
|
|
variation |
8 |
| calling |
1 |
tomography |
1 |
|
|
|
|
|
|
availability |
8 |
| work |
1 |
expressed |
1 |
|
|
|
|
|
|
alpha |
8 |
| should |
1 |
format |
1 |
|
|
|
|
|
|
space |
8 |
| metadata |
1 |
physiology |
1 |
|
|
|
|
|
|
against |
8 |
| alternative |
1 |
reactivity |
1 |
|
|
|
|
|
|
components |
8 |
| conductive |
1 |
receptor |
1 |
|
|
|
|
|
|
establish |
8 |
| gba |
1 |
reward |
1 |
|
|
|
|
|
|
powerful |
8 |
| vice |
1 |
distributions |
1 |
|
|
|
|
|
|
along |
8 |
| bioinformatics |
1 |
amr |
1 |
|
|
|
|
|
|
relationships |
8 |
| on |
1 |
equation |
1 |
|
|
|
|
|
|
life |
8 |
| hydroxyl |
1 |
regulation |
1 |
|
|
|
|
|
|
easily |
8 |
| p |
1 |
e |
1 |
|
|
|
|
|
|
improved |
8 |
| 6 |
1 |
substrate |
1 |
|
|
|
|
|
|
involved |
8 |
| introduced |
1 |
mechanisms |
1 |
|
|
|
|
|
|
variety |
8 |
| common |
1 |
icus |
1 |
|
|
|
|
|
|
enzymes |
8 |
| interchangeable |
1 |
throughout |
1 |
|
|
|
|
|
|
region |
8 |
| hypoxic |
1 |
pipeline |
1 |
|
|
|
|
|
|
roles |
8 |
| suicide |
1 |
rate |
1 |
|
|
|
|
|
|
processing |
8 |
| sequencers |
1 |
killing |
1 |
|
|
|
|
|
|
behavior |
8 |
| generally |
1 |
errors |
1 |
|
|
|
|
|
|
resulting |
8 |
| warning |
1 |
splitting |
1 |
|
|
|
|
|
|
core |
8 |
| layers |
1 |
damage |
1 |
|
|
|
|
|
|
diversity |
8 |
| clean |
1 |
desensitization |
1 |
|
|
|
|
|
|
viruses |
8 |
| signalling |
1 |
agonists |
1 |
|
|
|
|
|
|
probe |
8 |
| 269 |
1 |
kinetics |
1 |
|
|
|
|
|
|
self |
8 |
| composite |
1 |
models |
1 |
|
|
|
|
|
|
synthetic |
8 |
| 0 |
1 |
obtusa |
1 |
|
|
|
|
|
|
preparation |
8 |
| pathologies |
1 |
activation |
1 |
|
|
|
|
|
|
engineering |
8 |
| will |
1 |
comprehension |
1 |
|
|
|
|
|
|
image |
8 |
| amyloidogenesis |
1 |
antidepressants |
1 |
|
|
|
|
|
|
lack |
8 |
| lethality |
1 |
mruby2 |
1 |
|
|
|
|
|
|
kinetic |
8 |
| profiling |
1 |
progenitors |
1 |
|
|
|
|
|
|
peptide |
8 |
| within |
1 |
nct |
1 |
|
|
|
|
|
|
valuable |
8 |
| directed |
1 |
film |
1 |
|
|
|
|
|
|
shown |
8 |
| syn |
1 |
hydrolysis |
1 |
|
|
|
|
|
|
capable |
8 |
| virology |
1 |
required |
1 |
|
|
|
|
|
|
devices |
8 |
| priority |
1 |
pot |
1 |
|
|
|
|
|
|
interesting |
8 |
| organelle |
1 |
orientation |
1 |
|
|
|
|
|
|
vaccine |
8 |
| processes |
1 |
setup |
1 |
|
|
|
|
|
|
concentrations |
8 |
| user |
1 |
unstable |
1 |
|
|
|
|
|
|
rapidly |
8 |
| google |
1 |
complex |
1 |
|
|
|
|
|
|
unlikely |
8 |
| scanner |
1 |
injection |
1 |
|
|
|
|
|
|
patterns |
8 |
| environmental |
1 |
infections |
1 |
|
|
|
|
|
|
capacity |
8 |
| ampar |
1 |
invasions |
1 |
|
|
|
|
|
|
temperature |
8 |
| manner |
1 |
hours |
1 |
|
|
|
|
|
|
create |
8 |
| stoichiometric |
1 |
values |
1 |
|
|
|
|
|
|
genomes |
8 |
| canonical |
1 |
exchange |
1 |
|
|
|
|
|
|
spectroscopy |
8 |
| probe |
1 |
institutions |
1 |
|
|
|
|
|
|
graphene |
8 |
| ubiquitously |
1 |
other |
1 |
|
|
|
|
|
|
kinetics |
8 |
| safety |
1 |
crust |
1 |
|
|
|
|
|
|
real |
8 |
| spectrum |
1 |
study |
1 |
|
|
|
|
|
|
free |
8 |
| events |
1 |
biotechnology |
1 |
|
|
|
|
|
|
example |
8 |
| multimeric |
1 |
shot |
1 |
|
|
|
|
|
|
mutation |
8 |
| challenges |
1 |
as |
1 |
|
|
|
|
|
|
test |
8 |
| bipolar |
1 |
elucidated |
1 |
|
|
|
|
|
|
factor |
8 |
| however |
1 |
prioritization |
1 |
|
|
|
|
|
|
electronic |
8 |
| kinetic |
1 |
biocompatibility |
1 |
|
|
|
|
|
|
protocol |
8 |
| energy |
1 |
cqs |
1 |
|
|
|
|
|
|
hard |
8 |
| triggering |
1 |
responses |
1 |
|
|
|
|
|
|
spectrometry |
8 |
| signaling |
1 |
mammals |
1 |
|
|
|
|
|
|
characterization |
8 |
| phagolysosomal |
1 |
compounds |
1 |
|
|
|
|
|
|
association |
7 |
| underlying |
1 |
might |
1 |
|
|
|
|
|
|
cognitive |
7 |
| resolution |
1 |
core |
1 |
|
|
|
|
|
|
scalable |
7 |
| feature |
1 |
cyclization |
1 |
|
|
|
|
|
|
consequences |
7 |
| acquisition |
1 |
difficult |
1 |
|
|
|
|
|
|
showed |
7 |
| confounded |
1 |
functions |
1 |
|
|
|
|
|
|
testing |
7 |
| jejuni |
1 |
uptake |
1 |
|
|
|
|
|
|
interface |
7 |
| 25 |
1 |
day |
1 |
|
|
|
|
|
|
numerous |
7 |
| travel |
1 |
evidence |
1 |
|
|
|
|
|
|
temporal |
7 |
| others |
1 |
areas |
1 |
|
|
|
|
|
|
lower |
7 |
| 3d |
1 |
sequence |
1 |
|
|
|
|
|
|
users |
7 |
| property |
1 |
differences |
1 |
|
|
|
|
|
|
polymer |
7 |
| falsified |
1 |
nicotine |
1 |
|
|
|
|
|
|
power |
7 |
| saturation |
1 |
components |
1 |
|
|
|
|
|
|
complete |
7 |
| nmdar |
1 |
he |
1 |
|
|
|
|
|
|
obtain |
7 |
| gpr119 |
1 |
complexes |
1 |
|
|
|
|
|
|
described |
7 |
| other |
1 |
photoreactivy |
1 |
|
|
|
|
|
|
additional |
7 |
| n |
1 |
generation |
1 |
|
|
|
|
|
|
monitoring |
7 |
| ponds |
1 |
outcomes |
1 |
|
|
|
|
|
|
technological |
7 |
| both |
1 |
benefits |
1 |
|
|
|
|
|
|
despite |
7 |
| current |
1 |
length |
1 |
|
|
|
|
|
|
better |
7 |
| than |
1 |
chromatin |
1 |
|
|
|
|
|
|
contrast |
7 |
| detc |
1 |
noise |
1 |
|
|
|
|
|
|
conserved |
7 |
| measurements |
1 |
nature |
1 |
|
|
|
|
|
|
findings |
7 |
| phosphatidylcholine |
1 |
organelles |
1 |
|
|
|
|
|
|
able |
7 |
| spindle |
1 |
propionate |
1 |
|
|
|
|
|
|
generate |
7 |
| portable |
1 |
season |
1 |
|
|
|
|
|
|
emerging |
7 |
| species |
1 |
orr |
1 |
|
|
|
|
|
|
same |
7 |
| alkaline |
1 |
quasispecies |
1 |
|
|
|
|
|
|
chemistry |
7 |
| applications |
1 |
host |
1 |
|
|
|
|
|
|
investigate |
7 |
| enso |
1 |
particular |
1 |
|
|
|
|
|
|
d |
7 |
| zygote |
1 |
cd4bs |
1 |
|
|
|
|
|
|
provided |
7 |
| virus |
1 |
surfactant |
1 |
|
|
|
|
|
|
nuclear |
7 |
| aimed |
1 |
na |
1 |
|
|
|
|
|
|
given |
7 |
| few |
1 |
emissions |
1 |
|
|
|
|
|
|
cycle |
7 |
| against |
1 |
ring |
1 |
|
|
|
|
|
|
limit |
7 |
| chemistry |
1 |
diagnoses |
1 |
|
|
|
|
|
|
higher |
7 |
| parent |
1 |
molecules |
1 |
|
|
|
|
|
|
therapies |
7 |
| centrifuge |
1 |
had |
1 |
|
|
|
|
|
|
animal |
7 |
| integrated |
1 |
reported |
1 |
|
|
|
|
|
|
film |
7 |
| 8 |
1 |
modifier |
1 |
|
|
|
|
|
|
much |
7 |
| rflp |
1 |
vhl |
1 |
|
|
|
|
|
|
n |
7 |
| computing |
1 |
modification |
1 |
|
|
|
|
|
|
v |
7 |
| differences |
1 |
stability |
1 |
|
|
|
|
|
|
methodology |
7 |
| several |
1 |
rdt |
1 |
|
|
|
|
|
|
step |
7 |
| modern |
1 |
demand |
1 |
|
|
|
|
|
|
fundamental |
7 |
| graft |
1 |
year |
1 |
|
|
|
|
|
|
analyses |
7 |
| synthetic |
1 |
peptides |
1 |
|
|
|
|
|
|
quantitative |
7 |
| individual |
1 |
molecule |
1 |
|
|
|
|
|
|
derived |
7 |
| accumbens |
1 |
after |
1 |
|
|
|
|
|
|
microbial |
7 |
| spyring |
1 |
1970s |
1 |
|
|
|
|
|
|
what |
7 |
| balance |
1 |
stp |
1 |
|
|
|
|
|
|
20 |
7 |
| nuclear |
1 |
ade |
1 |
|
|
|
|
|
|
order |
7 |
| anisotropy |
1 |
macroglobulinemia |
1 |
|
|
|
|
|
|
care |
7 |
| biophysical |
1 |
li |
1 |
|
|
|
|
|
|
resource |
7 |
| matter |
1 |
decay |
1 |
|
|
|
|
|
|
aspects |
7 |
| kidney |
1 |
ml |
1 |
|
|
|
|
|
|
heterogeneity |
7 |
| quality |
1 |
risk |
1 |
|
|
|
|
|
|
distinguish |
7 |
| distinct |
1 |
lines |
1 |
|
|
|
|
|
|
13 |
7 |
| film |
1 |
relapse |
1 |
|
|
|
|
|
|
individuals |
7 |
| dna |
1 |
stiffness |
1 |
|
|
|
|
|
|
extinction |
7 |
| free |
1 |
neighborhood |
1 |
|
|
|
|
|
|
scientific |
7 |
| specification |
1 |
simultaneously |
1 |
|
|
|
|
|
|
gt |
7 |
| fos |
1 |
iplant |
1 |
|
|
|
|
|
|
bound |
7 |
| matrix |
1 |
fadh |
1 |
|
|
|
|
|
|
largely |
7 |
| rules |
1 |
rearrangements |
1 |
|
|
|
|
|
|
appealing |
7 |
| natural |
1 |
meaning |
1 |
|
|
|
|
|
|
computational |
7 |
| microreentrant |
1 |
formation |
1 |
|
|
|
|
|
|
resonance |
7 |
| intrinsic |
1 |
globally |
1 |
|
|
|
|
|
|
networks |
7 |
| force |
1 |
imprecision |
1 |
|
|
|
|
|
|
tested |
7 |
| recording |
1 |
instruments |
1 |
|
|
|
|
|
|
compatible |
7 |
| remodel |
1 |
expanded |
1 |
|
|
|
|
|
|
reads |
7 |
| mean |
1 |
nanoparticles |
1 |
|
|
|
|
|
|
flexibility |
7 |
| carp |
1 |
finally |
1 |
|
|
|
|
|
|
living |
7 |
| traumatic |
1 |
analyses |
1 |
|
|
|
|
|
|
electric |
7 |
| secretory |
1 |
481 |
1 |
|
|
|
|
|
|
experiences |
7 |
| mri |
1 |
roles |
1 |
|
|
|
|
|
|
oxygen |
7 |
| harm |
1 |
production |
1 |
|
|
|
|
|
|
together |
6 |
| viral |
1 |
assemblies |
1 |
|
|
|
|
|
|
needed |
6 |
| mammalian |
1 |
orf2p |
1 |
|
|
|
|
|
|
significance |
6 |
| site |
1 |
redundancy |
1 |
|
|
|
|
|
|
proposed |
6 |
| porcine |
1 |
minimal |
1 |
|
|
|
|
|
|
explore |
6 |
| towards |
1 |
language |
1 |
|
|
|
|
|
|
fields |
6 |
| carbon |
1 |
oligosanthes |
1 |
|
|
|
|
|
|
currently |
6 |
| triazole |
1 |
hypocapnia |
1 |
|
|
|
|
|
|
framework |
6 |
| determined |
1 |
morphology |
1 |
|
|
|
|
|
|
pathogen |
6 |
| discharge |
1 |
respectively |
1 |
|
|
|
|
|
|
infer |
6 |
| study |
1 |
immunity |
1 |
|
|
|
|
|
|
complement |
6 |
| variable |
1 |
biogenesis |
1 |
|
|
|
|
|
|
extremely |
6 |
| been |
1 |
requirements |
1 |
|
|
|
|
|
|
biosensor |
6 |
| genetic |
1 |
steel |
1 |
|
|
|
|
|
|
vaccination |
6 |
| metabolic |
1 |
conductivity |
1 |
|
|
|
|
|
|
date |
6 |
| per |
1 |
soil |
1 |
|
|
|
|
|
|
software |
6 |
| collagen |
1 |
databases |
1 |
|
|
|
|
|
|
produce |
6 |
| dioxide |
1 |
duplicates |
1 |
|
|
|
|
|
|
part |
6 |
| shortly |
1 |
ldi |
1 |
|
|
|
|
|
|
amenable |
6 |
| insertions |
1 |
traits |
1 |
|
|
|
|
|
|
portable |
6 |
| recognized |
1 |
achieved |
1 |
|
|
|
|
|
|
report |
6 |
| app |
1 |
fusion |
1 |
|
|
|
|
|
|
matter |
6 |
| homodont |
1 |
procedures |
1 |
|
|
|
|
|
|
distribution |
6 |
| hybridization |
1 |
|
|
|
|
|
|
|
|
outcomes |
6 |
| process |
1 |
|
|
|
|
|
|
|
|
organisms |
6 |
| approaches |
1 |
|
|
|
|
|
|
|
|
cause |
6 |
| waldenstrom |
1 |
|
|
|
|
|
|
|
|
knowledge |
6 |
| beyond |
1 |
|
|
|
|
|
|
|
|
transcription |
6 |
| mug |
1 |
|
|
|
|
|
|
|
|
background |
6 |
| infection |
1 |
|
|
|
|
|
|
|
|
measurements |
6 |
| seconds |
1 |
|
|
|
|
|
|
|
|
limitations |
6 |
| maize |
1 |
|
|
|
|
|
|
|
|
observe |
6 |
| evolving |
1 |
|
|
|
|
|
|
|
|
intermediate |
6 |
| offs |
1 |
|
|
|
|
|
|
|
|
versatile |
6 |
| accuracy |
1 |
|
|
|
|
|
|
|
|
impractical |
6 |
| conformational |
1 |
|
|
|
|
|
|
|
|
atmospheric |
6 |
| regions |
1 |
|
|
|
|
|
|
|
|
climate |
6 |
| emd |
1 |
|
|
|
|
|
|
|
|
direct |
6 |
| subtypes |
1 |
|
|
|
|
|
|
|
|
electrode |
6 |
| hiv |
1 |
|
|
|
|
|
|
|
|
amount |
6 |
| anoxic |
1 |
|
|
|
|
|
|
|
|
extensive |
6 |
| cement |
1 |
|
|
|
|
|
|
|
|
reconstruct |
6 |
| fluorescent |
1 |
|
|
|
|
|
|
|
|
targeting |
6 |
| ecosystems |
1 |
|
|
|
|
|
|
|
|
influence |
6 |
| significantly |
1 |
|
|
|
|
|
|
|
|
apply |
6 |
| functional |
1 |
|
|
|
|
|
|
|
|
convenient |
6 |
| may |
1 |
|
|
|
|
|
|
|
|
substrates |
6 |
| twin |
1 |
|
|
|
|
|
|
|
|
dual |
6 |
| gsk |
1 |
|
|
|
|
|
|
|
|
perform |
6 |
| epigenetic |
1 |
|
|
|
|
|
|
|
|
populations |
6 |
| major |
1 |
|
|
|
|
|
|
|
|
way |
6 |
| cytokine |
1 |
|
|
|
|
|
|
|
|
performed |
6 |
| their |
1 |
|
|
|
|
|
|
|
|
relevant |
6 |
| type |
1 |
|
|
|
|
|
|
|
|
fire |
6 |
| us |
1 |
|
|
|
|
|
|
|
|
challenges |
6 |
| simple |
1 |
|
|
|
|
|
|
|
|
efficiency |
6 |
| diagnostic |
1 |
|
|
|
|
|
|
|
|
investigating |
6 |
| universe |
1 |
|
|
|
|
|
|
|
|
overall |
6 |
| production |
1 |
|
|
|
|
|
|
|
|
increases |
6 |
| artemisinin |
1 |
|
|
|
|
|
|
|
|
coverage |
6 |
| contiguous |
1 |
|
|
|
|
|
|
|
|
signal |
6 |
| observations |
1 |
|
|
|
|
|
|
|
|
fluorescence |
6 |
| phagocytes |
1 |
|
|
|
|
|
|
|
|
reported |
6 |
| sources |
1 |
|
|
|
|
|
|
|
|
network |
6 |
| compartment |
1 |
|
|
|
|
|
|
|
|
interaction |
6 |
| as |
1 |
|
|
|
|
|
|
|
|
strategy |
6 |
| permeability |
1 |
|
|
|
|
|
|
|
|
regulatory |
6 |
| c |
1 |
|
|
|
|
|
|
|
|
larger |
6 |
| d |
1 |
|
|
|
|
|
|
|
|
signals |
6 |
| aa |
1 |
|
|
|
|
|
|
|
|
cortex |
6 |
| neuron |
1 |
|
|
|
|
|
|
|
|
thermal |
6 |
| biogeochemistry |
1 |
|
|
|
|
|
|
|
|
behavioral |
6 |
| antitumor |
1 |
|
|
|
|
|
|
|
|
dimensional |
6 |
| ribosome |
1 |
|
|
|
|
|
|
|
|
monitor |
6 |
| environments |
1 |
|
|
|
|
|
|
|
|
statistical |
6 |
| nanotechnology |
1 |
|
|
|
|
|
|
|
|
biomedical |
6 |
| public |
1 |
|
|
|
|
|
|
|
|
capture |
6 |
| presented |
1 |
|
|
|
|
|
|
|
|
positive |
6 |
| removal |
1 |
|
|
|
|
|
|
|
|
formation |
6 |
|
|
|
|
|
|
|
|
|
|
past |
6 |
|
|
|
|
|
|
|
|
|
|
reactions |
6 |
|
|
|
|
|
|
|
|
|
|
activation |
6 |
|
|
|
|
|
|
|
|
|
|
ph |
6 |
|
|
|
|
|
|
|
|
|
|
interference |
6 |
|
|
|
|
|
|
|
|
|
|
characterize |
6 |
|
|
|
|
|
|
|
|
|
|
basis |
6 |
|
|
|
|
|
|
|
|
|
|
appropriate |
6 |
|
|
|
|
|
|
|
|
|
|
solid |
6 |
|
|
|
|
|
|
|
|
|
|
reduced |
6 |
|
|
|
|
|
|
|
|
|
|
viral |
6 |
|
|
|
|
|
|
|
|
|
|
inhibition |
6 |
|
|
|
|
|
|
|
|
|
|
allow |
6 |
|
|
|
|
|
|
|
|
|
|
forces |
6 |
|
|
|
|
|
|
|
|
|
|
position |
6 |
|
|
|
|
|
|
|
|
|
|
broad |
6 |
|
|
|
|
|
|
|
|
|
|
lead |
6 |
|
|
|
|
|
|
|
|
|
|
readily |
6 |
|
|
|
|
|
|
|
|
|
|
diverse |
6 |
|
|
|
|
|
|
|
|
|
|
understood |
6 |
|
|
|
|
|
|
|
|
|
|
task |
6 |
|
|
|
|
|
|
|
|
|
|
times |
6 |
|
|
|
|
|
|
|
|
|
|
transport |
6 |
|
|
|
|
|
|
|
|
|
|
crucial |
6 |
|
|
|
|
|
|
|
|
|
|
provides |
6 |
|
|
|
|
|
|
|
|
|
|
simplicity |
6 |
|
|
|
|
|
|
|
|
|
|
beyond |
6 |
|
|
|
|
|
|
|
|
|
|
integrated |
6 |
|
|
|
|
|
|
|
|
|
|
central |
6 |
|
|
|
|
|
|
|
|
|
|
integration |
6 |
|
|
|
|
|
|
|
|
|
|
variations |
6 |
|
|
|
|
|
|
|
|
|
|
widely |
6 |
|
|
|
|
|
|
|
|
|
|
noise |
6 |
|
|
|
|
|
|
|
|
|
|
whereas |
6 |
|
|
|
|
|
|
|
|
|
|
malaria |
6 |
|
|
|
|
|
|
|
|
|
|
children |
6 |
|
|
|
|
|
|
|
|
|
|
distinct |
6 |
|
|
|
|
|
|
|
|
|
|
competitive |
6 |
|
|
|
|
|
|
|
|
|
|
next |
6 |
|
|
|
|
|
|
|
|
|
|
potent |
6 |
|
|
|
|
|
|
|
|
|
|
fusion |
6 |
|
|
|
|
|
|
|
|
|
|
earth |
6 |
|
|
|
|
|
|
|
|
|
|
ca |
6 |
|
|
|
|
|
|
|
|
|
|
quantify |
6 |
|
|
|
|
|
|
|
|
|
|
true |
6 |
|
|
|
|
|
|
|
|
|
|
domain |
6 |
|
|
|
|
|
|
|
|
|
|
local |
6 |
|
|
|
|
|
|
|
|
|
|
observations |
6 |
|
|
|
|
|
|
|
|
|
|
modern |
6 |
|
|
|
|
|
|
|
|
|
|
phenotype |
6 |
|
|
|
|
|
|
|
|
|
|
genomic |
6 |
|
|
|
|
|
|
|
|
|
|
p |
6 |
|
|
|
|
|
|
|
|
|
|
bacterial |
6 |
|
|
|
|
|
|
|
|
|
|
ecological |
6 |
|
|
|
|
|
|
|
|
|
|
blocking |
6 |
|
|
|
|
|
|
|
|
|
|
growing |
6 |
|
|
|
|
|
|
|
|
|
|
language |
6 |
|
|
|
|
|
|
|
|
|
|
standard |
6 |
|
|
|
|
|
|
|
|
|
|
multi |
6 |
|
|
|
|
|
|
|
|
|
|
co |
6 |
|
|
|
|
|
|
|
|
|
|
b |
6 |
|
|
|
|
|
|
|
|
|
|
mechanism |
6 |
|
|
|
|
|
|
|
|
|
|
minimal |
6 |
|
|
|
|
|
|
|
|
|
|
symptoms |
6 |
|
|
|
|
|
|
|
|
|
|
removal |
6 |
|
|
|
|
|
|
|
|
|
|
autophagy |
6 |
|
|
|
|
|
|
|
|
|
|
questions |
5 |
|
|
|
|
|
|
|
|
|
|
years |
5 |
|
|
|
|
|
|
|
|
|
|
anxiety |
5 |
|
|
|
|
|
|
|
|
|
|
transition |
5 |
|
|
|
|
|
|
|
|
|
|
similar |
5 |
|
|
|
|
|
|
|
|
|
|
groups |
5 |
|
|
|
|
|
|
|
|
|
|
graphical |
5 |
|
|
|
|
|
|
|
|
|
|
being |
5 |
|
|
|
|
|
|
|
|
|
|
commonly |
5 |
|
|
|
|
|
|
|
|
|
|
countries |
5 |
|
|
|
|
|
|
|
|
|
|
vaccines |
5 |
|
|
|
|
|
|
|
|
|
|
communities |
5 |
|
|
|
|
|
|
|
|
|
|
hence |
5 |
|
|
|
|
|
|
|
|
|
|
makes |
5 |
|
|
|
|
|
|
|
|
|
|
majority |
5 |
|
|
|
|
|
|
|
|
|
|
necessary |
5 |
|
|
|
|
|
|
|
|
|
|
compounds |
5 |
|
|
|
|
|
|
|
|
|
|
component |
5 |
|
|
|
|
|
|
|
|
|
|
history |
5 |
|
|
|
|
|
|
|
|
|
|
pre |
5 |
|
|
|
|
|
|
|
|
|
|
line |
5 |
|
|
|
|
|
|
|
|
|
|
improvement |
5 |
|
|
|
|
|
|
|
|
|
|
iii |
5 |
|
|
|
|
|
|
|
|
|
|
100 |
5 |
|
|
|
|
|
|
|
|
|
|
variable |
5 |
|
|
|
|
|
|
|
|
|
|
worldwide |
5 |
|
|
|
|
|
|
|
|
|
|
draw |
5 |
|
|
|
|
|
|
|
|
|
|
ii |
5 |
|
|
|
|
|
|
|
|
|
|
open |
5 |
|
|
|
|
|
|
|
|
|
|
cases |
5 |
|
|
|
|
|
|
|
|
|
|
radiation |
5 |
|
|
|
|
|
|
|
|
|
|
following |
5 |
|
|
|
|
|
|
|
|
|
|
sufficient |
5 |
|
|
|
|
|
|
|
|
|
|
half |
5 |
|
|
|
|
|
|
|
|
|
|
matrix |
5 |
|
|
|
|
|
|
|
|
|
|
almost |
5 |
|
|
|
|
|
|
|
|
|
|
concentration |
5 |
|
|
|
|
|
|
|
|
|
|
determination |
5 |
|
|
|
|
|
|
|
|
|
|
extent |
5 |
|
|
|
|
|
|
|
|
|
|
group |
5 |
|
|
|
|
|
|
|
|
|
|
sampling |
5 |
|
|
|
|
|
|
|
|
|
|
sources |
5 |
|
|
|
|
|
|
|
|
|
|
unprecedented |
5 |
|
|
|
|
|
|
|
|
|
|
practice |
5 |
|
|
|
|
|
|
|
|
|
|
pharmacological |
5 |
|
|
|
|
|
|
|
|
|
|
previous |
5 |
|
|
|
|
|
|
|
|
|
|
due |
5 |
|
|
|
|
|
|
|
|
|
|
flexible |
5 |
|
|
|
|
|
|
|
|
|
|
50 |
5 |
|
|
|
|
|
|
|
|
|
|
bulk |
5 |
|
|
|
|
|
|
|
|
|
|
dose |
5 |
|
|
|
|
|
|
|
|
|
|
negative |
5 |
|
|
|
|
|
|
|
|
|
|
agent |
5 |
|
|
|
|
|
|
|
|
|
|
activated |
5 |
|
|
|
|
|
|
|
|
|
|
selection |
5 |
|
|
|
|
|
|
|
|
|
|
error |
5 |
|
|
|
|
|
|
|
|
|
|
second |
5 |
|
|
|
|
|
|
|
|
|
|
disorders |
5 |
|
|
|
|
|
|
|
|
|
|
labeling |
5 |
|
|
|
|
|
|
|
|
|
|
release |
5 |
|
|
|
|
|
|
|
|
|
|
unlike |
5 |
|
|
|
|
|
|
|
|
|
|
uncertainty |
5 |
|
|
|
|
|
|
|
|
|
|
term |
5 |
|
|
|
|
|
|
|
|
|
|
nutrient |
5 |
|
|
|
|
|
|
|
|
|
|
storage |
5 |
|
|
|
|
|
|
|
|
|
|
indicate |
5 |
|
|
|
|
|
|
|
|
|
|
photosynthesis |
5 |
|
|
|
|
|
|
|
|
|
|
plants |
5 |
|
|
|
|
|
|
|
|
|
|
side |
5 |
|
|
|
|
|
|
|
|
|
|
increased |
5 |
|
|
|
|
|
|
|
|
|
|
accuracy |
5 |
|
|
|
|
|
|
|
|
|
|
crystalline |
5 |
|
|
|
|
|
|
|
|
|
|
affected |
5 |
|
|
|
|
|
|
|
|
|
|
mean |
5 |
|
|
|
|
|
|
|
|
|
|
exists |
5 |
|
|
|
|
|
|
|
|
|
|
selectively |
5 |
|
|
|
|
|
|
|
|
|
|
charge |
5 |
|
|
|
|
|
|
|
|
|
|
largest |
5 |
|
|
|
|
|
|
|
|
|
|
encodes |
5 |
|
|
|
|
|
|
|
|
|
|
best |
5 |
|
|
|
|
|
|
|
|
|
|
organic |
5 |
|
|
|
|
|
|
|
|
|
|
simultaneously |
5 |
|
|
|
|
|
|
|
|
|
|
describe |
5 |
|
|
|
|
|
|
|
|
|
|
nearly |
5 |
|
|
|
|
|
|
|
|
|
|
isolation |
5 |
|
|
|
|
|
|
|
|
|
|
extract |
5 |
|
|
|
|
|
|
|
|
|
|
oxidation |
5 |
|
|
|
|
|
|
|
|
|
|
correct |
5 |
|
|
|
|
|
|
|
|
|
|
orders |
5 |
|
|
|
|
|
|
|
|
|
|
laser |
5 |
|
|
|
|
|
|
|
|
|
|
subsequent |
5 |
|
|
|
|
|
|
|
|
|
|
researchers |
5 |
|
|
|
|
|
|
|
|
|
|
approximately |
5 |
|
|
|
|
|
|
|
|
|
|
infected |
5 |
|
|
|
|
|
|
|
|
|
|
lineage |
5 |
|
|
|
|
|
|
|
|
|
|
specifically |
5 |
|
|
|
|
|
|
|
|
|
|
strength |
5 |
|
|
|
|
|
|
|
|
|
|
l |
5 |
|
|
|
|
|
|
|
|
|
|
access |
5 |
|
|
|
|
|
|
|
|
|
|
introduced |
5 |
|
|
|
|
|
|
|
|
|
|
procedures |
5 |
|
|
|
|
|
|
|
|
|
|
out |
5 |
|
|
|
|
|
|
|
|
|
|
basic |
5 |
|
|
|
|
|
|
|
|
|
|
play |
5 |
|
|
|
|
|
|
|
|
|
|
metabolites |
5 |
|
|
|
|
|
|
|
|
|
|
reduction |
5 |
|
|
|
|
|
|
|
|
|
|
integrate |
5 |
|
|
|
|
|
|
|
|
|
|
demonstrated |
5 |
|
|
|
|
|
|
|
|
|
|
efficiently |
5 |
|
|
|
|
|
|
|
|
|
|
pressure |
5 |
|
|
|
|
|
|
|
|
|
|
substrate |
5 |
|
|
|
|
|
|
|
|
|
|
inhibitors |
5 |
|
|
|
|
|
|
|
|
|
|
context |
5 |
|
|
|
|
|
|
|
|
|
|
trial |
5 |
|
|
|
|
|
|
|
|
|
|
efficacy |
5 |
|
|
|
|
|
|
|
|
|
|
technical |
5 |
|
|
|
|
|
|
|
|
|
|
must |
5 |
|
|
|
|
|
|
|
|
|
|
k |
5 |
|
|
|
|
|
|
|
|
|
|
values |
5 |
|
|
|
|
|
|
|
|
|
|
metabolomics |
5 |
|
|
|
|
|
|
|
|
|
|
device |
5 |
|
|
|
|
|
|
|
|
|
|
follow |
5 |
|
|
|
|
|
|
|
|
|
|
cortical |
5 |
|
|
|
|
|
|
|
|
|
|
considerable |
5 |
|
|
|
|
|
|
|
|
|
|
algorithm |
5 |
|
|
|
|
|
|
|
|
|
|
far |
5 |
|
|
|
|
|
|
|
|
|
|
original |
5 |
|
|
|
|
|
|
|
|
|
|
90 |
5 |
|
|
|
|
|
|
|
|
|
|
requirements |
5 |
|
|
|
|
|
|
|
|
|
|
loss |
5 |
|
|
|
|
|
|
|
|
|
|
sites |
5 |
|
|
|
|
|
|
|
|
|
|
linear |
5 |
|
|
|
|
|
|
|
|
|
|
typical |
5 |
|
|
|
|
|
|
|
|
|
|
read |
5 |
|
|
|
|
|
|
|
|
|
|
seq |
5 |
|
|
|
|
|
|
|
|
|
|
enhanced |
5 |
|
|
|
|
|
|
|
|
|
|
prior |
5 |
|
|
|
|
|
|
|
|
|
|
cross |
5 |
|
|
|
|
|
|
|
|
|
|
invasion |
5 |
|
|
|
|
|
|
|
|
|
|
dependent |
5 |
|
|
|
|
|
|
|
|
|
|
made |
5 |
|
|
|
|
|
|
|
|
|
|
resolve |
5 |
|
|
|
|
|
|
|
|
|
|
burden |
5 |
|
|
|
|
|
|
|
|
|
|
extraction |
5 |
|
|
|
|
|
|
|
|
|
|
ease |
5 |
|
|
|
|
|
|
|
|
|
|
cocaine |
5 |
|
|
|
|
|
|
|
|
|
|
np |
5 |
|
|
|
|
|
|
|
|
|
|
working |
5 |
|
|
|
|
|
|
|
|
|
|
diagnosis |
5 |
|
|
|
|
|
|
|
|
|
|
acquisition |
5 |
|
|
|
|
|
|
|
|
|
|
inherent |
5 |
|
|
|
|
|
|
|
|
|
|
demands |
5 |
|
|
|
|
|
|
|
|
|
|
na |
5 |
|
|
|
|
|
|
|
|
|
|
identified |
5 |
|
|
|
|
|
|
|
|
|
|
community |
5 |
|
|
|
|
|
|
|
|
|
|
dengue |
5 |
|
|
|
|
|
|
|
|
|
|
bind |
5 |
|
|
|
|
|
|
|
|
|
|
family |
5 |
|
|
|
|
|
|
|
|
|
|
intrinsic |
5 |
|
|
|
|
|
|
|
|
|
|
architecture |
4 |
|
|
|
|
|
|
|
|
|
|
track |
4 |
|
|
|
|
|
|
|
|
|
|
altered |
4 |
|
|
|
|
|
|
|
|
|
|
periods |
4 |
|
|
|
|
|
|
|
|
|
|
stimuli |
4 |
|
|
|
|
|
|
|
|
|
|
straightforward |
4 |
|
|
|
|
|
|
|
|
|
|
spin |
4 |
|
|
|
|
|
|
|
|
|
|
predictions |
4 |
|
|
|
|
|
|
|
|
|
|
communication |
4 |
|
|
|
|
|
|
|
|
|
|
algorithms |
4 |
|
|
|
|
|
|
|
|
|
|
presented |
4 |
|
|
|
|
|
|
|
|
|
|
faster |
4 |
|
|
|
|
|
|
|
|
|
|
introduction |
4 |
|
|
|
|
|
|
|
|
|
|
resources |
4 |
|
|
|
|
|
|
|
|
|
|
databases |
4 |
|
|
|
|
|
|
|
|
|
|
find |
4 |
|
|
|
|
|
|
|
|
|
|
problems |
4 |
|
|
|
|
|
|
|
|
|
|
namely |
4 |
|
|
|
|
|
|
|
|
|
|
led |
4 |
|
|
|
|
|
|
|
|
|
|
medical |
4 |
|
|
|
|
|
|
|
|
|
|
quickly |
4 |
|
|
|
|
|
|
|
|
|
|
engineer |
4 |
|
|
|
|
|
|
|
|
|
|
mice |
4 |
|
|
|
|
|
|
|
|
|
|
third |
4 |
|
|
|
|
|
|
|
|
|
|
widespread |
4 |
|
|
|
|
|
|
|
|
|
|
billion |
4 |
|
|
|
|
|
|
|
|
|
|
solar |
4 |
|
|
|
|
|
|
|
|
|
|
reflect |
4 |
|
|
|
|
|
|
|
|
|
|
origin |
4 |
|
|
|
|
|
|
|
|
|
|
importance |
4 |
|
|
|
|
|
|
|
|
|
|
tissues |
4 |
|
|
|
|
|
|
|
|
|
|
appear |
4 |
|
|
|
|
|
|
|
|
|
|
causes |
4 |
|
|
|
|
|
|
|
|
|
|
pd |
4 |
|
|
|
|
|
|
|
|
|
|
relationship |
4 |
|
|
|
|
|
|
|
|
|
|
rare |
4 |
|
|
|
|
|
|
|
|
|
|
sds |
4 |
|
|
|
|
|
|
|
|
|
|
his |
4 |
|
|
|
|
|
|
|
|
|
|
efforts |
4 |
|
|
|
|
|
|
|
|
|
|
period |
4 |
|
|
|
|
|
|
|
|
|
|
alignment |
4 |
|
|
|
|
|
|
|
|
|
|
severity |
4 |
|
|
|
|
|
|
|
|
|
|
prevention |
4 |
|
|
|
|
|
|
|
|
|
|
domains |
4 |
|
|
|
|
|
|
|
|
|
|
humans |
4 |
|
|
|
|
|
|
|
|
|
|
overexpressed |
4 |
|
|
|
|
|
|
|
|
|
|
choice |
4 |
|
|
|
|
|
|
|
|
|
|
modulate |
4 |
|
|
|
|
|
|
|
|
|
|
alter |
4 |
|
|
|
|
|
|
|
|
|
|
people |
4 |
|
|
|
|
|
|
|
|
|
|
accurate |
4 |
|
|
|
|
|
|
|
|
|
|
parameters |
4 |
|
|
|
|
|
|
|
|
|
|
topology |
4 |
|
|
|
|
|
|
|
|
|
|
reveal |
4 |
|
|
|
|
|
|
|
|
|
|
capability |
4 |
|
|
|
|
|
|
|
|
|
|
antimicrobial |
4 |
|
|
|
|
|
|
|
|
|
|
d2 |
4 |
|
|
|
|
|
|
|
|
|
|
status |
4 |
|
|
|
|
|
|
|
|
|
|
hand |
4 |
|
|
|
|
|
|
|
|
|
|
property |
4 |
|
|
|
|
|
|
|
|
|
|
electrochemical |
4 |
|
|
|
|
|
|
|
|
|
|
leading |
4 |
|
|
|
|
|
|
|
|
|
|
affect |
4 |
|
|
|
|
|
|
|
|
|
|
newly |
4 |
|
|
|
|
|
|
|
|
|
|
pathogens |
4 |
|
|
|
|
|
|
|
|
|
|
catalytic |
4 |
|
|
|
|
|
|
|
|
|
|
activities |
4 |
|
|
|
|
|
|
|
|
|
|
atoms |
4 |
|
|
|
|
|
|
|
|
|
|
compartment |
4 |
|
|
|
|
|
|
|
|
|
|
procedure |
4 |
|
|
|
|
|
|
|
|
|
|
inexpensive |
4 |
|
|
|
|
|
|
|
|
|
|
treat |
4 |
|
|
|
|
|
|
|
|
|
|
implicated |
4 |
|
|
|
|
|
|
|
|
|
|
organelles |
4 |
|
|
|
|
|
|
|
|
|
|
proteome |
4 |
|
|
|
|
|
|
|
|
|
|
reagent |
4 |
|
|
|
|
|
|
|
|
|
|
nanoparticles |
4 |
|
|
|
|
|
|
|
|
|
|
respond |
4 |
|
|
|
|
|
|
|
|
|
|
instance |
4 |
|
|
|
|
|
|
|
|
|
|
do |
4 |
|
|
|
|
|
|
|
|
|
|
driven |
4 |
|
|
|
|
|
|
|
|
|
|
c3 |
4 |
|
|
|
|
|
|
|
|
|
|
targets |
4 |
|
|
|
|
|
|
|
|
|
|
mapping |
4 |
|
|
|
|
|
|
|
|
|
|
subcellular |
4 |
|
|
|
|
|
|
|
|
|
|
improving |
4 |
|
|
|
|
|
|
|
|
|
|
fragmentation |
4 |
|
|
|
|
|
|
|
|
|
|
build |
4 |
|
|
|
|
|
|
|
|
|
|
still |
4 |
|
|
|
|
|
|
|
|
|
|
spectral |
4 |
|
|
|
|
|
|
|
|
|
|
muscle |
4 |
|
|
|
|
|
|
|
|
|
|
wall |
4 |
|
|
|
|
|
|
|
|
|
|
delivery |
4 |
|
|
|
|
|
|
|
|
|
|
mirnas |
4 |
|
|
|
|
|
|
|
|
|
|
age |
4 |
|
|
|
|
|
|
|
|
|
|
degradation |
4 |
|
|
|
|
|
|
|
|
|
|
greatly |
4 |
|
|
|
|
|
|
|
|
|
|
unit |
4 |
|
|
|
|
|
|
|
|
|
|
nm |
4 |
|
|
|
|
|
|
|
|
|
|
typically |
4 |
|
|
|
|
|
|
|
|
|
|
alone |
4 |
|
|
|
|
|
|
|
|
|
|
european |
4 |
|
|
|
|
|
|
|
|
|
|
continuous |
4 |
|
|
|
|
|
|
|
|
|
|
least |
4 |
|
|
|
|
|
|
|
|
|
|
differential |
4 |
|
|
|
|
|
|
|
|
|
|
generated |
4 |
|
|
|
|
|
|
|
|
|
|
lacks |
4 |
|
|
|
|
|
|
|
|
|
|
compare |
4 |
|
|
|
|
|
|
|
|
|
|
comparable |
4 |
|
|
|
|
|
|
|
|
|
|
price |
4 |
|
|
|
|
|
|
|
|
|
|
hydrogen |
4 |
|
|
|
|
|
|
|
|
|
|
stage |
4 |
|
|
|
|
|
|
|
|
|
|
requires |
4 |
|
|
|
|
|
|
|
|
|
|
cycles |
4 |
|
|
|
|
|
|
|
|
|
|
advanced |
4 |
|
|
|
|
|
|
|
|
|
|
prevalence |
4 |
|
|
|
|
|
|
|
|
|
|
help |
4 |
|
|
|
|
|
|
|
|
|
|
decades |
4 |
|
|
|
|
|
|
|
|
|
|
built |
4 |
|
|
|
|
|
|
|
|
|
|
reagents |
4 |
|
|
|
|
|
|
|
|
|
|
fraction |
4 |
|
|
|
|
|
|
|
|
|
|
ionic |
4 |
|
|
|
|
|
|
|
|
|
|
m |
4 |
|
|
|
|
|
|
|
|
|
|
stochastic |
4 |
|
|
|
|
|
|
|
|
|
|
before |
4 |
|
|
|
|
|
|
|
|
|
|
case |
4 |
|
|
|
|
|
|
|
|
|
|
electrical |
4 |
|
|
|
|
|
|
|
|
|
|
ideally |
4 |
|
|
|
|
|
|
|
|
|
|
learning |
4 |
|
|
|
|
|
|
|
|
|
|
producing |
4 |
|
|
|
|
|
|
|
|
|
|
fate |
4 |
|
|
|
|
|
|
|
|
|
|
exploring |
4 |
|
|
|
|
|
|
|
|
|
|
entire |
4 |
|
|
|
|
|
|
|
|
|
|
modification |
4 |
|
|
|
|
|
|
|
|
|
|
compound |
4 |
|
|
|
|
|
|
|
|
|
|
onset |
4 |
|
|
|
|
|
|
|
|
|
|
result |
4 |
|
|
|
|
|
|
|
|
|
|
memories |
4 |
|
|
|
|
|
|
|
|
|
|
presents |
4 |
|
|
|
|
|
|
|
|
|
|
applied |
4 |
|
|
|
|
|
|
|
|
|
|
projects |
4 |
|
|
|
|
|
|
|
|
|
|
assessing |
4 |
|
|
|
|
|
|
|
|
|
|
band |
4 |
|
|
|
|
|
|
|
|
|
|
fast |
4 |
|
|
|
|
|
|
|
|
|
|
catalyst |
4 |
|
|
|
|
|
|
|
|
|
|
15 |
4 |
|
|
|
|
|
|
|
|
|
|
leads |
4 |
|
|
|
|
|
|
|
|
|
|
battery |
4 |
|
|
|
|
|
|
|
|
|
|
poorly |
4 |
|
|
|
|
|
|
|
|
|
|
variability |
4 |
|
|
|
|
|
|
|
|
|
|
nucleic |
4 |
|
|
|
|
|
|
|
|
|
|
accurately |
4 |
|
|
|
|
|
|
|
|
|
|
literature |
4 |
|
|
|
|
|
|
|
|
|
|
late |
4 |
|
|
|
|
|
|
|
|
|
|
selectivity |
4 |
|
|
|
|
|
|
|
|
|
|
tuning |
4 |
|
|
|
|
|
|
|
|
|
|
normal |
4 |
|
|
|
|
|
|
|
|
|
|
reference |
4 |
|
|
|
|
|
|
|
|
|
|
phenotypes |
4 |
|
|
|
|
|
|
|
|
|
|
vary |
4 |
|
|
|
|
|
|
|
|
|
|
world |
4 |
|
|
|
|
|
|
|
|
|
|
interplay |
4 |
|
|
|
|
|
|
|
|
|
|
sensor |
4 |
|
|
|
|
|
|
|
|
|
|
full |
4 |
|
|
|
|
|
|
|
|
|
|
conservation |
4 |
|
|
|
|
|
|
|
|
|
|
areas |
4 |
|
|
|
|
|
|
|
|
|
|
complementary |
4 |
|
|
|
|
|
|
|
|
|
|
versatility |
4 |
|
|
|
|
|
|
|
|
|
|
controlled |
4 |
|
|
|
|
|
|
|
|
|
|
profiles |
4 |
|
|
|
|
|
|
|
|
|
|
lc |
4 |
|
|
|
|
|
|
|
|
|
|
balance |
4 |
|
|
|
|
|
|
|
|
|
|
connections |
4 |
|
|
|
|
|
|
|
|
|
|
datasets |
4 |
|
|
|
|
|
|
|
|
|
|
analyze |
4 |
|
|
|
|
|
|
|
|
|
|
programming |
4 |
|
|
|
|
|
|
|
|
|
|
optimal |
4 |
|
|
|
|
|
|
|
|
|
|
mirna |
4 |
|
|
|
|
|
|
|
|
|
|
circulating |
4 |
|
|
|
|
|
|
|
|
|
|
produced |
4 |
|
|
|
|
|
|
|
|
|
|
smaller |
4 |
|
|
|
|
|
|
|
|
|
|
reducing |
4 |
|
|
|
|
|
|
|
|
|
|
severe |
4 |
|
|
|
|
|
|
|
|
|
|
concept |
4 |
|
|
|
|
|
|
|
|
|
|
focus |
4 |
|
|
|
|
|
|
|
|
|
|
separate |
4 |
|
|
|
|
|
|
|
|
|
|
preferred |
4 |
|
|
|
|
|
|
|
|
|
|
thousands |
4 |
|
|
|
|
|
|
|
|
|
|
containing |
4 |
|
|
|
|
|
|
|
|
|
|
generally |
4 |
|
|
|
|
|
|
|
|
|
|
require |
4 |
|
|
|
|
|
|
|
|
|
|
so |
4 |
|
|
|
|
|
|
|
|
|
|
fold |
4 |
|
|
|
|
|
|
|
|
|
|
c4 |
4 |
|
|
|
|
|
|
|
|
|
|
element |
4 |
|
|
|
|
|
|
|
|
|
|
mammalian |
4 |
|
|
|
|
|
|
|
|
|
|
wnt |
4 |
|
|
|
|
|
|
|
|
|
|
ligands |
4 |
|
|
|
|
|
|
|
|
|
|
day |
4 |
|
|
|
|
|
|
|
|
|
|
atp |
4 |
|
|
|
|
|
|
|
|
|
|
class |
4 |
|
|
|
|
|
|
|
|
|
|
finally |
4 |
|
|
|
|
|
|
|
|
|
|
pancreatic |
4 |
|
|
|
|
|
|
|
|
|
|
stem |
4 |
|
|
|
|
|
|
|
|
|
|
pain |
4 |
|
|
|
|
|
|
|
|
|
|
minimize |
4 |
|
|
|
|
|
|
|
|
|
|
ratio |
4 |
|
|
|
|
|
|
|
|
|
|
replication |
4 |
|
|
|
|
|
|
|
|
|
|
improve |
4 |
|
|
|
|
|
|
|
|
|
|
policy |
4 |
|
|
|
|
|
|
|
|
|
|
ray |
4 |
|
|
|
|
|
|
|
|
|
|
identification |
4 |
|
|
|
|
|
|
|
|
|
|
channels |
4 |
|
|
|
|
|
|
|
|
|
|
agents |
4 |
|
|
|
|
|
|
|
|
|
|
get |
4 |
|
|
|
|
|
|
|
|
|
|
safety |
4 |
|
|
|
|
|
|
|
|
|
|
array |
4 |
|
|
|
|
|
|
|
|
|
|
marker |
4 |
|
|
|
|
|
|
|
|
|
|
theoretical |
4 |
|
|
|
|
|
|
|
|
|
|
amplification |
4 |
|
|
|
|
|
|
|
|
|
|
eye |
4 |
|
|
|
|
|
|
|
|
|
|
analyzing |
4 |
|
|
|
|
|
|
|
|
|
|
reporting |
4 |
|
|
|
|
|
|
|
|
|
|
degree |
4 |
|
|
|
|
|
|
|
|
|
|
developments |
4 |
|
|
|
|
|
|
|
|
|
|
contains |
4 |
|
|
|
|
|
|
|
|
|
|
traditional |
4 |
|
|
|
|
|
|
|
|
|
|
become |
4 |
|
|
|
|
|
|
|
|
|
|
industrial |
4 |
|
|
|
|
|
|
|
|
|
|
initiation |
4 |
|
|
|
|
|
|
|
|
|
|
predicted |
4 |
|
|
|
|
|
|
|
|
|
|
strongly |
4 |
|
|
|
|
|
|
|
|
|
|
95 |
4 |
|
|
|
|
|
|
|
|
|
|
loading |
4 |
|
|
|
|
|
|
|
|
|
|
translation |
4 |
|
|
|
|
|
|
|
|
|
|
enables |
4 |
|
|
|
|
|
|
|
|
|
|
organization |
4 |
|
|
|
|
|
|
|
|
|
|
conclude |
4 |
|
|
|
|
|
|
|
|
|
|
biomarker |
4 |
|
|
|
|
|
|
|
|
|
|
search |
4 |
|
|
|
|
|
|
|
|
|
|
li |
4 |
|
|
|
|
|
|
|
|
|
|
meet |
4 |
|
|
|
|
|
|
|
|
|
|
via |
4 |
|
|
|
|
|
|
|
|
|
|
platforms |
4 |
|
|
|
|
|
|
|
|
|
|
nitrogen |
4 |
|
|
|
|
|
|
|
|
|
|
cellulose |
4 |
|
|
|
|
|
|
|
|
|
|
co2 |
4 |
|
|
|
|
|
|
|
|
|
|
back |
4 |
|
|
|
|
|
|
|
|
|
|
make |
4 |
|
|
|
|
|
|
|
|
|
|
defined |
4 |
|
|
|
|
|
|
|
|
|
|
decay |
4 |
|
|
|
|
|
|
|
|
|
|
feedback |
4 |
|
|
|
|
|
|
|
|
|
|
index |
4 |
|
|
|
|
|
|
|
|
|
|
advancements |
4 |
|
|
|
|
|
|
|
|
|
|
gated |
4 |
|
|
|
|
|
|
|
|
|
|
define |
4 |
|
|
|
|
|
|
|
|
|
|
hormone |
4 |
|
|
|
|
|
|
|
|
|
|
consumption |
4 |
|
|
|
|
|
|
|
|
|
|
season |
4 |
|
|
|
|
|
|
|
|
|
|
management |
4 |
|
|
|
|
|
|
|
|
|
|
heat |
4 |
|
|
|
|
|
|
|
|
|
|
sole |
4 |
|
|
|
|
|
|
|
|
|
|
public |
4 |
|
|
|
|
|
|
|
|
|
|
throughout |
4 |
|
|
|
|
|
|
|
|
|
|
diagnosed |
4 |
|
|
|
|
|
|
|
|
|
|
another |
4 |
|
|
|
|
|
|
|
|
|
|
exchange |
4 |
|
|
|
|
|
|
|
|
|
|
atom |
4 |
|
|
|
|
|
|
|
|
|
|
rules |
4 |
|
|
|
|
|
|
|
|
|
|
fact |
4 |
|
|
|
|
|
|
|
|
|
|
benefit |
4 |
|
|
|
|
|
|
|
|
|
|
comprehensive |
4 |
|
|
|
|
|
|
|
|
|
|
remains |
4 |
|
|
|
|
|
|
|
|
|
|
ampar |
4 |
|
|
|
|
|
|
|
|
|
|
experiment |
4 |
|
|
|
|
|
|
|
|
|
|
constant |
4 |
|
|
|
|
|
|
|
|
|
|
catabolic |
4 |
|
|
|
|
|
|
|
|
|
|
adult |
4 |
|
|
|
|
|
|
|
|
|
|
tnt1 |
4 |
|
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。